PMC:7402624 / 582-737 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":33,"end":38},"obj":"Body_part"},{"id":"T6","span":{"begin":70,"end":80},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62863"}],"text":"s reaching \u003e30% of circulating B cells. However, another subgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immuno"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":31,"end":38},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T12","span":{"begin":81,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"s reaching \u003e30% of circulating B cells. However, another subgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immuno"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T5","span":{"begin":70,"end":91},"obj":"http://purl.obolibrary.org/obo/GO_0046649"}],"text":"s reaching \u003e30% of circulating B cells. However, another subgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immuno"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":40,"end":126},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"s reaching \u003e30% of circulating B cells. However, another subgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immuno"}